AstraZeneca Turned 7% Revenue Growth Into 20% Profit Growth
Hey there, bargain hunter. Not every great drug company announces a cancer moonshot this morning. Some just quietly convert modest…
Newsletters
My new warning
October 30, 2026 Bonus Content: AbbVie Already Told You About the $216M Charge. Now Check If the Dividend Is Safe….
Elon Musk… A Total Fraud?
October 29, 2026 Bonus Content: Apple Has $146 Billion. The One Deal That Fixes Its AI Gap. A note from…
Lloyds Just Doubled Its Profit. Shares Are Still Off The High.
October 29, 2026 The Budget punished UK banks less than feared Sponsored Cash first, questions later Here’s how most same-day…
Marc Chaikin’s #1 AI Stock for 2027
October 29, 2026 Bonus Content: Ford’s $4.7 Billion Quarter: The Dividend Math A note from our friends at MarketWise(ad) Editor’s…
Every brand needs intelligence.
October 29, 2026 Bonus Content: D.R. Horton Closes FY2026 With Mortgage Rates at 7.4% A note from our friends at…
SK Hynix Still Trades Below 4x Earnings.
October 28, 2026 A record quarter, a $75 billion return plan, and a valuation the market keeps refusing to believe….
Your book is inside
October 28, 2026 Bonus Content: Mercedes Is Paying You 8.7% to Wait. The Risk Is a Longer Wait. A note…
The AI secret few investors understand
October 28, 2026 Bonus Content: Stellantis Lost Money Again. Here Is What Has to Change. A note from our friends…
Porsche Sells Fewer Cars and Calls It a Strategy. Is It Working?
Hey there, bargain hunter. Porsche just handed you the first clean quarterly read on CEO Michael Leiters’ turnaround plan, and…